1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Ophthalmic Diagnostic Equipment - Medical Devices Pipeline Assessment, 2016

Ophthalmic Diagnostic Equipment - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, “Ophthalmic Diagnostic Equipment - Medical Devices Pipeline Assessment, 2016" provides an overview of Ophthalmic Diagnostic Equipment currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Ophthalmic Diagnostic Equipment pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Ophthalmic Diagnostic Equipment under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Ophthalmic Diagnostic Equipment and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Ophthalmic Diagnostic Equipment under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table Of Contents

Ophthalmic Diagnostic Equipment - Medical Devices Pipeline Assessment, 2016
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 15
2 Introduction 16
2.1 Ophthalmic Diagnostic Equipment Overview 16
3 Products under Development 19
3.1 Ophthalmic Diagnostic Equipment - Pipeline Products by Stage of Development 19
3.2 Ophthalmic Diagnostic Equipment - Pipeline Products by Segment 20
3.3 Ophthalmic Diagnostic Equipment - Pipeline Products by Territory 21
3.4 Ophthalmic Diagnostic Equipment - Pipeline Products by Regulatory Path 22
3.5 Ophthalmic Diagnostic Equipment - Pipeline Products by Estimated Approval Date 23
3.6 Ophthalmic Diagnostic Equipment - Ongoing Clinical Trials 24
4 Ophthalmic Diagnostic Equipment - Pipeline Products under Development by Companies 25
4.1 Ophthalmic Diagnostic Equipment Companies - Pipeline Products by Stage of Development 25
4.2 Ophthalmic Diagnostic Equipment - Pipeline Products by Stage of Development 29
5 Ophthalmic Diagnostic Equipment Companies and Product Overview 33
5.1 AcuMEMS Company Overview 33
5.2 Aeon Imaging, LLC Company Overview 36
5.3 Arizona State University Company Overview 37
5.4 Avedro Inc Company Overview 38
5.5 Baylor College of Medicine Company Overview 39
5.6 BioFormatix, Inc. Company Overview 43
5.7 Boston Micromachines Corporation Company Overview 44
5.8 Brockman-Hastings LLC Company Overview 45
5.9 Canon U.S.A., Inc. Company Overview 46
5.10 Cardiff University Company Overview 50
5.11 Case Western Reserve University Company Overview 51
5.12 CeeMax Ophthalmics Company Overview 52
5.13 Centro de Investigacion Biomedica en Red en Bioingenieria Biomateriales y Nanomedicina Company Overview 53
5.14 ChromoLogic LLC Company Overview 55
5.15 Cleveland Clinic Hospital Company Overview 56
5.16 Coland Holdings Company Limited Company Overview 57
5.17 Compact Imaging Inc. Company Overview 60
5.18 DigitalVision, LLC Company Overview 61
5.19 Dioptrix Company Overview 62
5.20 Duke University Company Overview 63
5.21 El-Vision Ltd. Company Overview 67
5.22 Epvsensors, LLC Company Overview 68
5.23 Eye Care and Cure Company Overview 71
5.24 eyeMITRA Company Overview 72
5.25 Eyenuk Inc. Company Overview 73
5.26 George Washington University Company Overview 75
5.27 Hadasit Medical Research Services and Development Ltd Company Overview 76
5.28 Hadassah Medical Center Company Overview 77
5.29 Heidelberg Engineering GmbH Company Overview 78
5.30 Heriot-Watt University Company Overview 80
5.31 Icare Finland Oy Company Overview 81
5.32 Imperial College London Company Overview 85
5.33 Implandata Ophthalmic Products GmbH Company Overview 86
5.34 Indian Institute of Technology Bombay Company Overview 90
5.35 i-Optics BV Company Overview 91
5.36 Iowa State University Company Overview 93
5.37 iSonic Medical Company Overview 94
5.38 John Hopkins University Company Overview 96
5.39 Kowa Company Ltd Company Overview 97
5.40 LaunchPoint Technologies, Inc. Company Overview 98
5.41 Leica Microsystems GmbH Company Overview 99
5.42 Lumetrics Inc Company Overview 103
5.43 MacCure Company Overview 107
5.44 Maculogix, Inc. Company Overview 108
5.45 Medical University of South Carolina Company Overview 109
5.46 Nagasaki University Company Overview 110
5.47 National Taiwan University Hospital Company Overview 111
5.48 National University of Ireland, Galway Company Overview 112
5.49 Neuro Kinetics, Inc. Company Overview 113
5.50 OptoQuest Company Overview 114
5.51 Optos Plc Company Overview 115
5.52 Optovue Inc Company Overview 119
5.53 PAIR Technologies LLC Company Overview 120
5.54 Paradigm Medical Industries, Inc. (Inactive) Company Overview 121
5.55 RetinalGenix, Inc. Company Overview 122
5.56 Retinostics Company Overview 123
5.57 Rice University Company Overview 124
5.58 Rutgers The State University of New Jersey Company Overview 126
5.59 Scalar Bioscience, LLC Company Overview 127
5.60 Sheba Medical Center Company Overview 128
5.61 Sinoora Inc. Company Overview 129
5.62 SOLX Inc Company Overview 130
5.63 Stanford University Company Overview 131
5.64 Stellenbosch University Company Overview 132
5.65 Structured Eye Ltd Company Overview 133
5.66 Tear Diagno LLC Company Overview 134
5.67 The Chinese University of Hong Kong Company Overview 135
5.68 The Hong Kong University of Science and Technology Company Overview 136
5.69 The National Digital Research Centre Limited Company Overview 137
5.70 Tissot Medical Research SA Company Overview 138
5.71 University of Arizona Company Overview 139
5.72 University of California Berkeley Company Overview 141
5.73 University of California Los Angeles Company Overview 143
5.74 University of California San Diego Company Overview 144
5.75 University of California San Francisco Company Overview 145
5.76 University of Edinburgh Company Overview 146
5.77 University of Pecs Company Overview 147
5.78 University of Rochester Company Overview 148
5.79 University of South Florida Company Overview 149
5.80 University of Valencia Company Overview 150
5.81 University of Washington Company Overview 151
5.82 VisionQuest Biomedical, LLC Company Overview 152
5.83 Visual Pathways, Inc. (Inactive) Company Overview 154
5.84 ViVO Smart Medical Devices Ltd. Company Overview 156
5.85 Volcano Corp Company Overview 157
5.86 Welch Allyn Inc Company Overview 158
5.87 Ziemer Ophthalmic Systems AG Company Overview 159
6 Ophthalmic Diagnostic Equipment- Recent Developments 161
6.1 Nov 07, 2016: OPKO Health Reports Third Quarter Financial and Operating Results 161
6.2 Nov 07, 2016: TearLab Reports Third Quarter and September Year-To-Date 2016 Financial Results 162
6.3 Nov 02, 2016: NOVADAQ Reports Third Quarter 2016 Financial Results 163
6.4 Nov 01, 2016: Oclaro Announces First Quarter Fiscal Year 2017 Financial Results 163
6.5 Oct 26, 2016: Salt Lake City Eye Doctors Say First FDA-Approved Corneal Cross-Linking Treatment is Now Available in Utah 164
6.6 Oct 18, 2016: LumiThera to Raise USD5 Million in Venture Financing 165
6.7 Oct 13, 2016: Carl Zeiss Meditec appoints Steven C. Schallhorn, MD as Chief Medical Officer 165
6.8 Oct 11, 2016: Nicox third quarter 2016 business update and cash position 166
6.9 Oct 10, 2016: Vance Thompson Vision Contributes to FDA Approval of Corneal Crosslinking for treating Keratoconus 167
6.10 Oct 07, 2016: Vance Thompson Vision Contributes to FDA Approval of Corneal Crosslinking for treating Keratoconus 167
6.11 Sep 28, 2016: First FDA Approved Cross-Linking Procedures Are Performed on Patients in the U.S. with Progressive Keratoconus 168
6.12 Sep 28, 2016: Hill-Rom Adding More Than 100 Jobs In Central New York 169
6.13 Sep 22, 2016: Nicox first half 2016 business and financial update 170
6.14 Sep 19, 2016: Innokas and Icare Finland signed a manufacturing agreement 171
6.15 Sep 16, 2016: Johnson and Johnson to Acquire Abbott Medical Optics from Abbott Laboratories for USD4.32 Billion 171
6.16 Sep 13, 2016: OPKO Health Appoints Jane Pine Wood as Chief Legal and Compliance Officer of BioReference Laboratories 172
6.17 Sep 09, 2016: KKR Invests USD66 Million in AcuFocus 172
6.18 Sep 08, 2016: Avedro Appoints Dr. Reza Zadno As Chief Executive Officer 172
6.19 Sep 06, 2016: Ellex to Launch New Ophthalmic Ultrasound Device 173
6.20 Sep 01, 2016: Paul Kealey Named Senior Vice President of Corporate Development for Visunex Medical 173
6.21 Aug 29, 2016: Oclaro Appoints Global Human Resources Veteran to Board of Directors 174
6.22 Aug 12, 2016: Carl Zeiss Meditec Grows in Ophthalmology and Microsurgery 174
6.23 Aug 10, 2016: Acufocus Raises USD2 Million in Venture Financing 175
6.24 Aug 08, 2016: Optovue Announces New Distribution Agreement With ROCOL in Colombia 175
6.25 Aug 08, 2016: OPKO Health Reports Improved Financial and Operating Results 175
6.26 Aug 03, 2016: TearLab Reports Second Quarter and June Year-To-Date 2016 Financial Results 176
6.27 Aug 02, 2016: Eckert and Ziegler BEBIG: First Half-Year Results 2016 Published 177
6.28 Aug 02, 2016: Oclaro Announces Fourth Quarter and Fiscal Year 2016 Financial Results 180
6.29 Aug 01, 2016: Notal Vision Appoints Dr. Susan Orr as Chief Medical Officer and Vice President of Medical Affairs 181
6.30 Jul 28, 2016: Nicox to Raise USD20 Million in Private Placement of Shares 181
6.31 Jul 27, 2016: NOVADAQ Reports Second Quarter 2016 Financial Results 182
6.32 Jul 27, 2016: Carl Zeiss Meditec Recruits James V. Mazzo to Lead Its Newly Consolidated Ophthalmology Organization 182
6.33 Jul 25, 2016: LaunchPoint Announces New Analytics Executive 183
6.34 Jul 22, 2016: Baylor Genetics rebrand makes debut with simplified name, targeted message 183
6.35 Jul 20, 2016: Carl Zeiss Meditec announces change to Management Board 184
6.36 Jul 19, 2016: Avedro Receives Additional Indication for Photrexa Viscous, Photrexa and the KXL System for the Treatment of Corneal Ectasia following Refractive Surgery 184
6.37 Jul 06, 2016: NOVADAQ Announces Appointment of Rick Mangat as President and CEO 185
6.38 Jun 29, 2016: NeuroVision Imaging Raises USD10 Million in Series B Venture Financing 186
6.39 Jun 24, 2016: AcuFocus Raises USD1.9 Million in Venture Financing 186
6.40 Jun 16, 2016: REBIScan Receives FDA Clearance for the Pediatric Vision Scanner 186
6.41 Jun 13, 2016: OPKO Health Announces Move to NASDAQ Stock Market 187
6.42 Jun 01, 2016: Optovue Announces New AngioVue Retina Imaging System Commercial Availability 187
6.43 May 16, 2016: Escalon Medical Reports Third Quarter Fiscal 2016 Results 188
6.44 May 11, 2016: Carl Zeiss Meditec Records Revenue Growth of 8.6 Percent 188
6.45 May 11, 2016: Nephros Reports First Quarter 2016 Financial Results 189
6.46 May 10, 2016: Nicox first quarter 2016 financial and business update 191
6.47 May 09, 2016: Durrie Vision Contributes to FDA Approval of Corneal Crosslinking for Treating Keratoconus 191
6.48 May 09, 2016: Recent Studies Have Shown New Cataract Technologies From ZEISS Achieve Excellent Refractive Outcomes and a Reduced Risk of Refractive Surprises 192
6.49 May 09, 2016: OPKO Health Reports First Quarter Financial and Operating Results 194
6.50 May 04, 2016: TearLab Prices Public Offering of Shares and Warrants for USD17.3 Million 195
6.51 May 04, 2016: TearLab Reports Q1-16 Financial Results 195
6.52 Apr 29, 2016: ZEISS on Course to Further Growth 196
6.53 Apr 27, 2016: NOVADAQ Reports First Quarter 2016 Financial Results 197
6.54 Apr 25, 2016: Revenio Group Interim Report January 1 - March 31, 2016 197
6.55 Apr 20, 2016: Revenio Group: The Icare Ic100 Has Received a Sales Permit For The US Markets 199
6.56 Apr 20, 2016: TearLab Announces First Quarter 2016 Preliminary Financial Estimates 199
6.57 Apr 18, 2016: Avedro Receives FDA Approval for Photrexa Viscous, Photrexa and the KXL System for Corneal Cross-Linking 200
6.58 Apr 15, 2016: Nicox: 2015 Financial Results and Business Update 201
6.59 Apr 12, 2016: iSTAR Medical Raises USD11.4 Million in Series B Financing 203
6.60 Apr 04, 2016: Carl Zeiss Meditec achieves revenue growth of approximately 9% in first half year 2015/16 203
6.61 Mar 28, 2016: Easy and Effective Functional Test for Pediatric Ophthalmology Assessment with RETeval CompleteTouted by Early Adopters 203
6.62 Mar 17, 2016: Revenio says FDA did not grant sales permit for Icare HOME in US 204
6.63 Mar 15, 2016: OPKO Health Names Dr. Gregory Henderson President of Bio-Reference Laboratories 204
6.64 Mar 09, 2016: Visunex Receives FDA Clearance on PANOCAM PRO Wide-Field Imaging System 205
6.65 Mar 08, 2016: TearLab Reports Fourth Quarter and Full Year 2015 Financial Results 206
6.66 Feb 29, 2016: Notal Vision Achieves Medicare Coverage For ForeseeHome 207
6.67 Feb 29, 2016: TearLab Announces Strategic Restructuring 207
6.68 Feb 29, 2016: OPKO Announces Financial and Operating Results 208
6.69 Feb 25, 2016: Nicox reports strong revenue growth in 2015 and provides corporate update 210
6.70 Feb 24, 2016: OPKO's GeneDx Participating in the Molecular Medicine Tri-Conference 2016 in San Francisco 211
6.71 Feb 17, 2016: NOVADAQ Reports Fourth Quarter and Full Year 2015 Financial Results 212
6.72 Feb 12, 2016: Optovue's AngioVue Imaging System Receives FDA Clearance 213
6.73 Feb 12, 2016: Carl Zeiss Meditec Grows, Boosted by Currency Tailwinds / Strongest Growth Once Again in Surgical Ophthalmology 213
6.74 Feb 09, 2016: Zeiss AngioPlex Optical Coherence Tomography Angiography of the Retinal Microvasculature May Help Enhance Understanding of Retinal Disease 214
6.75 Feb 03, 2016: Optovue Releases AngioAnalytics, World's First OCTA Blood Vessel Measurement Technology 215
6.76 Feb 01, 2016: TearLab Withdraws Public Offering of Shares for up to USD15 Million 215
6.77 Feb 01, 2016: TearLab Announces Fourth Quarter 2015 Preliminary Financial Estimates and Provides Corporate Update 216
6.78 Jan 11, 2016: NOVADAQ Announces Fourth Quarter 2015 Preliminary Unaudited Revenues and Issues 2016 Revenue Guidance 217
6.79 Jan 11, 2016: Bausch + Lomb Announces 2016 Elite Vendor Relationship with Vision Source 217
6.80 Dec 28, 2015: HealPros Raises Funds in Series A Financing 218
6.81 Dec 17, 2015: Halma Acquires Visiometrics 218
6.82 Dec 16, 2015: AEA Investors to Acquire Majority Stake in 1-800 Contacts from Thomas H. Lee Partners 218
6.83 Dec 16, 2015: Carl Zeiss Meditec increases revenue to € 1,040 million / Market shares expanded in a number of markets 219
6.84 Dec 14, 2015: Leica receives FDA approval for EnFocus OCT 220
6.85 Dec 03, 2015: NIDEK launches the Anterior Chamber Angle mode for TONOPACHY NT-530P 220
7 Appendix 221
7.1 Methodology 221
7.2 About GlobalData 224
7.3 Contact Us 224
7.4 Disclaimer 224

1.1
List of Tables

Table 1: Ophthalmic Diagnostic Equipment - Pipeline Products by Stage of Development 21
Table 2: Ophthalmic Diagnostic Equipment - Pipeline Products by Segment 22
Table 3: Ophthalmic Diagnostic Equipment - Pipeline Products by Territory 23
Table 4: Ophthalmic Diagnostic Equipment - Pipeline Products by Regulatory Path 24
Table 5: Ophthalmic Diagnostic Equipment - Pipeline Products by Estimated Approval Date 25
Table 6: Ophthalmic Diagnostic Equipment - Ongoing Clinical Trials 26
Table 7: Ophthalmic Diagnostic Equipment Companies - Pipeline Products by Stage of Development 27
Table 8: Ophthalmic Diagnostic Equipment - Pipeline Products by Stage of Development 31
Table 9: AcuMEMS Pipeline Products and Ongoing Clinical Trials Overview 35
Table 10: IOP Sensor - Anterior Chamber - Product Status 35
Table 11: IOP Sensor - Anterior Chamber - Product Description 35
Table 12: IOP Sensor - Posterior Chamber - Product Status 36
Table 13: IOP Sensor - Posterior Chamber - Product Description 36
Table 14: iSense System - Product Status 36
Table 15: iSense System - Product Description 37
Table 16: Aeon Imaging, LLC Pipeline Products and Ongoing Clinical Trials Overview 38
Table 17: Laser Scanning Digital Camera Stimulator - Product Status 38
Table 18: Laser Scanning Digital Camera Stimulator - Product Description 38
Table 19: Arizona State University Pipeline Products and Ongoing Clinical Trials Overview 39
Table 20: Hand-Held Tonometer - Glaucoma - Product Status 39
Table 21: Hand-Held Tonometer - Glaucoma - Product Description 39
Table 22: Avedro Inc Pipeline Products and Ongoing Clinical Trials Overview 40
Table 23: Brillouin Scanning Microscope - Product Status 40
Table 24: Brillouin Scanning Microscope - Product Description 40
Table 25: Baylor College of Medicine Pipeline Products and Ongoing Clinical Trials Overview 41
Table 26: HOCD Device - Product Status 41
Table 27: HOCD Device - Product Description 42
Table 28: Baylor College of Medicine - Ongoing Clinical Trials Overview 43
Table 29: HOCD Device - Use of a Novel, Objective Optokinetic Contrast Device to Determine Scotopic Range Visual Function and Discriminate Between Patients with and without Glaucoma 44
Table 30: BioFormatix, Inc. Pipeline Products and Ongoing Clinical Trials Overview 45
Table 31: VirtualEye Perimeter - Product Status 45
Table 32: VirtualEye Perimeter - Product Description 45
Table 33: Boston Micromachines Corporation Pipeline Products and Ongoing Clinical Trials Overview 46
Table 34: Next Generation Adaptive Optics Scanning Laser Ophthalmoscope - Product Status 46
Table 35: Next Generation Adaptive Optics Scanning Laser Ophthalmoscope - Product Description 46
Table 36: Brockman-Hastings LLC Pipeline Products and Ongoing Clinical Trials Overview 47
Table 37: IOP Sensor - Product Status 47
Table 38: IOP Sensor - Product Description 47
Table 39: Canon U.S.A., Inc. Pipeline Products and Ongoing Clinical Trials Overview 48
Table 40: AOSLO (Adaptive Optics Scanning Laser Ophthalmoscopy) Based System - Product Status 48
Table 41: AOSLO (Adaptive Optics Scanning Laser Ophthalmoscopy) Based System - Product Description 49
Table 42: SPOCT HR - Product Status 49
Table 43: SPOCT HR - Product Description 49
Table 44: Canon U.S.A., Inc. - Ongoing Clinical Trials Overview 50
Table 45: AOSLO (Adaptive Optics Scanning Laser Ophthalmoscopy) Based System - High Resolution Retinal Imaging in Patients with Inherited Retinal Degenerations 51
Table 46: AOSLO (Adaptive Optics Scanning Laser Ophthalmoscopy) Based System - Photoreceptor Structure in A Phase 2 Study of Encapsulated Human NTC-201 Cell Implants Releasing Ciliary Neurotrophic Factor (CNTF) for Participants with Retinitis Pigmentosa Using Rates of Change in Cone Spacing and Density 51
Table 47: Cardiff University Pipeline Products and Ongoing Clinical Trials Overview 52
Table 48: Retinal Densitometer - Product Status 52
Table 49: Retinal Densitometer - Product Description 52
Table 50: Case Western Reserve University Pipeline Products and Ongoing Clinical Trials Overview 53
Table 51: Two-photon Ophthalmoscope - Product Status 53
Table 52: Two-photon Ophthalmoscope - Product Description 53
Table 53: CeeMax Ophthalmics Pipeline Products and Ongoing Clinical Trials Overview 54
Table 54: In-Home Tonometer - Product Status 54
Table 55: In-Home Tonometer - Product Description 54
Table 56: Centro de Investigacion Biomedica en Red en Bioingenieria Biomateriales y Nanomedicina Pipeline Products and Ongoing Clinical Trials Overview 55
Table 57: Lente Sensora - Product Status 55
Table 58: Lente Sensora - Product Description 56
Table 59: Sensing Contact Lens - Product Status 56
Table 60: Sensing Contact Lens - Product Description 56
Table 61: ChromoLogic LLC Pipeline Products and Ongoing Clinical Trials Overview 57
Table 62: Ocular Flare Meter - Product Status 57
Table 63: Ocular Flare Meter - Product Description 57
Table 64: Cleveland Clinic Hospital Pipeline Products and Ongoing Clinical Trials Overview 58
Table 65: Interoperative OCT System - Product Status 58
Table 66: Interoperative OCT System - Product Description 58
Table 67: Coland Holdings Company Limited Pipeline Products and Ongoing Clinical Trials Overview 59
Table 68: High-End Retina Microscope - Product Status 59
Table 69: High-End Retina Microscope - Product Description 59
Table 70: Ophthalmic Laser Scanning Fundus Photographic Instrument - Product Status 60
Table 71: Ophthalmic Laser Scanning Fundus Photographic Instrument - Product Description 60
Table 72: Portable Fundus Camera - Product Status 60
Table 73: Portable Fundus Camera - Product Description 61
Table 74: Compact Imaging Inc. Pipeline Products and Ongoing Clinical Trials Overview 62
Table 75: MRO Optical Imaging Sensor - Product Status 62
Table 76: MRO Optical Imaging Sensor - Product Description 62
Table 77: DigitalVision, LLC Pipeline Products and Ongoing Clinical Trials Overview 63
Table 78: VisionOptimizer - Product Status 63
Table 79: VisionOptimizer - Product Description 63
Table 80: Dioptrix Pipeline Products and Ongoing Clinical Trials Overview 64
Table 81: Hawk Eye - Product Status 64
Table 82: Hawk Eye - Product Description 64
Table 83: Duke University Pipeline Products and Ongoing Clinical Trials Overview 65
Table 84: HH - SDOCT - Product Status 65
Table 85: HH - SDOCT - Product Description 66
Table 86: Microscope Integrated OCT System - Product Status 66
Table 87: Microscope Integrated OCT System - Product Description 66
Table 88: Duke University - Ongoing Clinical Trials Overview 67
Table 89: Microscope Integrated OCT System - Intraoperative OCT Guidance of Intraocular Surgery 68
Table 90: El-Vision Ltd. Pipeline Products and Ongoing Clinical Trials Overview 69
Table 91: OcuTest - Product Status 69
Table 92: OcuTest - Product Description 69
Table 93: Epvsensors, LLC Pipeline Products and Ongoing Clinical Trials Overview 70
Table 94: Retinal Photometer - Product Status 70
Table 95: Retinal Photometer - Product Description 71
Table 96: Tactile Tonometer TT001 - Product Status 71
Table 97: Tactile Tonometer TT001 - Product Description 72
Table 98: Eye Care and Cure Pipeline Products and Ongoing Clinical Trials Overview 73
Table 99: Diagnostic Device - Eye Alignment - Product Status 73
Table 100: Diagnostic Device - Eye Alignment - Product Description 73
Table 101: eyeMITRA Pipeline Products and Ongoing Clinical Trials Overview 74
Table 102: eyeMITRA Device - Product Status 74
Table 103: eyeMITRA Device - Product Description 74
Table 104: Eyenuk Inc. Pipeline Products and Ongoing Clinical Trials Overview 75
Table 105: EyeMark - Product Status 75
Table 106: EyeMark - Product Description 75
Table 107: EyeSeeAMD - Product Status 76
Table 108: EyeSeeAMD - Product Description 76
Table 109: George Washington University Pipeline Products and Ongoing Clinical Trials Overview 77
Table 110: Amplified Bimorph Scanning Mirror System - Product Status 77
Table 111: Amplified Bimorph Scanning Mirror System - Product Description 77
Table 112: Hadasit Medical Research Services and Development Ltd Pipeline Products and Ongoing Clinical Trials Overview 78
Table 113: Automated Visual Acuity Device - Product Status 78
Table 114: Automated Visual Acuity Device - Product Description 78
Table 115: Hadassah Medical Center Pipeline Products and Ongoing Clinical Trials Overview 79
Table 116: Optic Neuritis Visual Test - Product Status 79
Table 117: Optic Neuritis Visual Test - Product Description 79
Table 118: Heidelberg Engineering GmbH Pipeline Products and Ongoing Clinical Trials Overview 80
Table 119: Cataract And Refractive Imaging Platform - Product Status 80
Table 120: Cataract And Refractive Imaging Platform - Product Description 81
Table 121: SPECTRALIS OCT2 Module - OCT Angiography - Product Status 81
Table 122: SPECTRALIS OCT2 Module - OCT Angiography - Product Description 81
Table 123: Heriot-Watt University Pipeline Products and Ongoing Clinical Trials Overview 82
Table 124: Non-Invasive Cataract Diagnostic Tool - Product Status 82
Table 125: Non-Invasive Cataract Diagnostic Tool - Product Description 82
Table 126: Icare Finland Oy Pipeline Products and Ongoing Clinical Trials Overview 83
Table 127: Icare HOME Tonometer - Product Status 83
Table 128: Icare HOME Tonometer - Product Description 84
Table 129: Icare Finland Oy - Ongoing Clinical Trials Overview 85
Table 130: Icare HOME Tonometer - The Effect of Trabeculectomy, Glaucoma Drainage Device, Cyclophotocoagulation, and Ocular Hypotensive Eye-drops on Intraocular Pressure Fluctuation with Postural Change in Eyes with Open-angle Glaucoma 86
Table 131: Imperial College London Pipeline Products and Ongoing Clinical Trials Overview 87
Table 132: Intraocular Wireless Pressure Sensing Implant - Product Status 87
Table 133: Intraocular Wireless Pressure Sensing Implant - Product Description 87
Table 134: Implandata Ophthalmic Products GmbH Pipeline Products and Ongoing Clinical Trials Overview 88
Table 135: ARGOS-EO - Product Status 88
Table 136: ARGOS-EO - Product Description 88
Table 137: ARGOS-IO - Product Status 89
Table 138: ARGOS-IO - Product Description 89
Table 139: Implandata Ophthalmic Products GmbH - Ongoing Clinical Trials Overview 90
Table 140: ARGOS-IO - A Prospective Open-label, Multicenter Clinical Investigation to Assess the Safety and Performance of ARGOS-IO System in Patients Undergoing Implantation of a Boston Keratoprosthesis (BKPro) 91
Table 141: ARGOS-IO - A Prospective, Open-label, Multicenter Clinical Investigation to Assess the Safety and Performance of the ARGOS-IO System in Patients with Primary Open Angle Glaucoma (POAG) 91
Table 142: Indian Institute of Technology Bombay Pipeline Products and Ongoing Clinical Trials Overview 92
Table 143: Glaucoma Screener - Product Status 92
Table 144: Glaucoma Screener - Product Description 92
Table 145: i-Optics BV Pipeline Products and Ongoing Clinical Trials Overview 93
Table 146: 1KHz Retina Tracker - Product Status 93
Table 147: 1KHz Retina Tracker - Product Description 93
Table 148: Superresolution Image Enhancement - Product Status 94
Table 149: Superresolution Image Enhancement - Product Description 94
Table 150: Iowa State University Pipeline Products and Ongoing Clinical Trials Overview 95
Table 151: Glaucoma Detection Device - Product Status 95
Table 152: Glaucoma Detection Device - Product Description 95
Table 153: iSonic Medical Pipeline Products and Ongoing Clinical Trials Overview 96
Table 154: Telemedical Homecare Tonometer - Product Status 96
Table 155: Telemedical Homecare Tonometer - Product Description 96
Table 156: Vibration Tonometer - Product Status 97
Table 157: Vibration Tonometer - Product Description 97
Table 158: John Hopkins University Pipeline Products and Ongoing Clinical Trials Overview 98
Table 159: Fundus Imaging System - Product Status 98
Table 160: Fundus Imaging System - Product Description 98
Table 161: Kowa Company Ltd Pipeline Products and Ongoing Clinical Trials Overview 99
Table 162: VX-10a - Fundus Autofluorescence - Product Status 99
Table 163: VX-10a - Fundus Autofluorescence - Product Description 99
Table 164: LaunchPoint Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 100
Table 165: Intraocular Pressure Sensor - Product Status 100
Table 166: Intraocular Pressure Sensor - Product Description 100
Table 167: Leica Microsystems GmbH Pipeline Products and Ongoing Clinical Trials Overview 101
Table 168: DI-SDOCT Imaging System - Product Status 101
Table 169: DI-SDOCT Imaging System - Product Description 102
Table 170: Microscope Integrated Intraoperative OCT - Product Status 102
Table 171: Microscope Integrated Intraoperative OCT - Product Description 103
Table 172: SDOCT Scanner - Product Status 103
Table 173: SDOCT Scanner - Product Description 104
Table 174: Lumetrics Inc Pipeline Products and Ongoing Clinical Trials Overview 105
Table 175: Axial Length Eye Measurement System - Product Status 105
Table 176: Axial Length Eye Measurement System - Product Description 105
Table 177: Fundus Camera - Product Status 106
Table 178: Fundus Camera - Product Description 106
Table 179: Lumetrics Inc - Ongoing Clinical Trials Overview 107
Table 180: Fundus Camera - The Impact of Telemedicine System to the Diagnosis and Treatment of Diabetes Retinopathy in Rural Canton 108
Table 181: MacCure Pipeline Products and Ongoing Clinical Trials Overview 109
Table 182: Opthalmic Diagnostic Device - Macular Degeneration - Product Status 109
Table 183: Opthalmic Diagnostic Device - Macular Degeneration - Product Description 109
Table 184: Maculogix, Inc. Pipeline Products and Ongoing Clinical Trials Overview 110
Table 185: AdaptDx - AMD - Product Status 110
Table 186: AdaptDx - AMD - Product Description 110
Table 187: Medical University of South Carolina Pipeline Products and Ongoing Clinical Trials Overview 111
Table 188: Retinal Disease Evaluation Device - Product Status 111
Table 189: Retinal Disease Evaluation Device - Product Description 111
Table 190: Nagasaki University Pipeline Products and Ongoing Clinical Trials Overview 112
Table 191: Corneal Trans-epithelial Electrical Resistance Measurement Device - Product Status 112
Table 192: Corneal Trans-epithelial Electrical Resistance Measurement Device - Product Description 112
Table 193: National Taiwan University Hospital Pipeline Products and Ongoing Clinical Trials Overview 113
Table 194: Pupillometer - Product Status 113
Table 195: Pupillometer - Product Description 113
Table 196: National University of Ireland, Galway Pipeline Products and Ongoing Clinical Trials Overview 114
Table 197: MacPi Screening Tool - Product Status 114
Table 198: MacPi Screening Tool - Product Description 114
Table 199: Neuro Kinetics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 115
Table 200: I-Portal Retinopathy - Product Status 115
Table 201: I-Portal Retinopathy - Product Description 115
Table 202: OptoQuest Pipeline Products and Ongoing Clinical Trials Overview 116
Table 203: Vectralis - Product Status 116
Table 204: Vectralis - Product Description 116
Table 205: Optos Plc Pipeline Products and Ongoing Clinical Trials Overview 117
Table 206: Early Detection Device - Eye Disease - Product Status 117
Table 207: Early Detection Device - Eye Disease - Product Description 118
Table 208: Falcon I - Product Status 118
Table 209: Falcon I - Product Description 119
Table 210: Falcon II - Product Status 119
Table 211: Falcon II - Product Description 119
Table 212: Lotte - Product Status 120
Table 213: Lotte - Product Description 120
Table 214: Optovue Inc Pipeline Products and Ongoing Clinical Trials Overview 121
Table 215: AngioAnalytics - Product Status 121
Table 216: AngioAnalytics - Product Description 121
Table 217: PAIR Technologies LLC Pipeline Products and Ongoing Clinical Trials Overview 122
Table 218: Cataract Diagnostic Device - Product Status 122
Table 219: Cataract Diagnostic Device - Product Description 122
Table 220: Paradigm Medical Industries, Inc. (Inactive) Pipeline Products and Ongoing Clinical Trials Overview 123
Table 221: Paramax - Product Status 123
Table 222: Paramax - Product Description 123
Table 223: RetinalGenix, Inc. Pipeline Products and Ongoing Clinical Trials Overview 124
Table 224: RetinalGeniX System - Product Status 124
Table 225: RetinalGeniX System - Product Description 124
Table 226: Retinostics Pipeline Products and Ongoing Clinical Trials Overview 125
Table 227: Ultra-high Resolution Scanning Laser Ophthalmoscope - Product Status 125
Table 228: Ultra-high Resolution Scanning Laser Ophthalmoscope - Product Description 125
Table 229: Rice University Pipeline Products and Ongoing Clinical Trials Overview 126
Table 230: Diagnostic Device - Dry Eye - Product Status 126
Table 231: Diagnostic Device - Dry Eye - Product Description 127
Table 232: Rutgers The State University of New Jersey Pipeline Products and Ongoing Clinical Trials Overview 128
Table 233: Tonometer - Product Status 128
Table 234: Tonometer - Product Description 128
Table 235: Scalar Bioscience, LLC Pipeline Products and Ongoing Clinical Trials Overview 129
Table 236: MacScope - Product Status 129
Table 237: MacScope - Product Description 129
Table 238: Sheba Medical Center Pipeline Products and Ongoing Clinical Trials Overview 130
Table 239: Automatized Chromatic Perimetry Test Device - Product Status 130
Table 240: Automatized Chromatic Perimetry Test Device - Product Description 130
Table 241: Sinoora Inc. Pipeline Products and Ongoing Clinical Trials Overview 131
Table 242: On-chip Spectral Coherence Tomography System - Product Status 131
Table 243: On-chip Spectral Coherence Tomography System - Product Description 131
Table 244: SOLX Inc Pipeline Products and Ongoing Clinical Trials Overview 132

1.2
List of Figures

Figure 1: Ophthalmic Diagnostic Equipment - Pipeline Products by Stage of Development 21
Figure 2: Ophthalmic Diagnostic Equipment - Pipeline Products by Segment 22
Figure 3: Ophthalmic Diagnostic Equipment - Pipeline Products by Territory 23
Figure 4: Ophthalmic Diagnostic Equipment - Pipeline Products by Regulatory Path 24
Figure 5: Ophthalmic Diagnostic Equipment - Pipeline Products by Estimated Approval Date 25
Figure 6: Ophthalmic Diagnostic Equipment - Ongoing Clinical Trials 26

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.